Innovative policy to prevent mother-to-child transmission of HIV shows positive impact - Press Release
The number of pregnant and breastfeeding women in Malawi with HIV who started life-saving antiretroviral treatment increased by more than 700 percent in one year, according to a study in CDC's Morbidity and Mortality Weekly Report. The new treatment option, called Option B+, offers all pregnant or breastfeeding women infected with HIV lifelong antiretroviral treatment (ART), regardless of the stage of their HIV infection.
The number of pregnant and breastfeeding women in Malawi with HIV who started life-saving antiretroviral treatment increased by more than 700 percent in one year, according to a study in CDC's Morbidity and Mortality Weekly Report. The new treatment option, called Option B+, offers all pregnant or breastfeeding women infected with HIV lifelong antiretroviral treatment (ART), regardless of the stage of their HIV infection.
This Coalition transmission preserves metadata, trust context, and source routing for a Public Intelligence item from CDC. The complete article remains with the original publisher.
Content handling is marked as Public Domain. Use the source article link for the full report, updates, corrections, and publisher-controlled context.
Key Points
- Published by CDC.
- Categorized as Public Intelligence.
- Source handling: Verified Source.
- Rights posture: Public Domain.
- Follow the source article for the complete original report.